Davis Polk advised the underwriters in the offering. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000 American depositary shares, each representing two ordinary […]
Legend Biotech’s $403 Million Shares Offering
Revolution Medicines’ $230 Million Shares Offering
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten […]
ChargePoint Holdings’ $500 Million At-The-Market Offering
Davis Polk advised the sales agents in the offering. ChargePoint Holdings, Inc. finalized a $500 million SEC-registered at-the-market offering of its common stock. ChargePoint’s common stock is […]
Investcorp India Acquisition Corp’s $225 Million Initial Public Offering
Winston & Strawn represented Investcorp India Acquisition Corp in the IPO, while Davis Polk advised the underwriter. Investcorp India Acquisition Corp (NASDAQ: IVCAU), a newly incorporated […]
Hayward Holdings’ $348 Million Secondary Offering
Ropes & Gray advised Hayward, while Davis Polk advised the several underwriters in the offering. Hayward Holdings, Inc. executed a $348 million follow-on public offering of its […]
Excelerate Energy’s $384 Million Initial Public Offering
Gibson, Dunn & Crutcher advised Excelerate Energy, while Davis Polk advised the representatives of the several underwriters in the IPO. Excelerate Energy, Inc. announced the $384 million […]
CCC Intelligent Solutions Holdings’ $194 Million Shares Offering
Kirkland & Ellis advised Davis Polk advised CCC Intelligent Solutions Holdings, while the representatives of the several underwriters in the offering. CCC Intelligent Solutions Holdings Inc. […]
Workday’s $3 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers in the offering while Fenwick represented Workday. Workday, Inc. executed an $3 billion SEC-registered debt offering. The offering consisted of $1 […]
AN2 Therapeutics’ $69 Million Initial Public Offering
Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of […]
Valuence Merger Corp. I’s $200 Million Initial Public Offering
Davis Polk advised the representative of the underwriters, SVB Securities LLC and Robert W. Baird & Co. Incorporated in the IPO. Walkers acted as Cayman Islands […]
LatAmGrowth SPAC’s $130 Million Initial Public Offering
Shearman & Sterling and Davis Polk advised on the offering. LatAmGrowth SPAC announced its initial public offering of 13,000,000 units, for aggregate proceeds of $130 million. Each […]
Heartland Media Acquisition’s $175 Million Initial Public Offering
Proskauer advised Heartland Media Acquisition Corp., while Davis Polk advised the underwriters in the offering. Heartland Media Acquisition Corp. executed the initial public offering of 17,500,000 units, […]